Investigating the Biden Administration’s COVID-19 Vaccine Approval Process: Oversight and Accountability in the Administrative State.

On Wednesday, June 26, 2024, at 10:00 a.m. ET, the House Judiciary Subcommittee on the Administrative State, Regulatory Reform, and Antitrust will hold a hearing titled “Follow the Science?: Oversight of the Biden Covid-19 Administrative State Response.” The subcommittee will focus on its findings regarding the Biden Administration’s influence on the FDA to expedite the approval of the Pfizer COVID-19 vaccine and boosters.

During the hearing, congress will discuss potential reforms to ensure greater accountability within the administrative state, specifically when it comes to the approval process for vaccines. The witnesses scheduled to testify include Dr. Philip Krause, MD, former Deputy Director of the FDA Office of Vaccines Research & Review, Aaron Siri, a vaccine litigation expert, Jordan Vaughn, MD, Founder and President of the Microvascular Research Foundation in Birmingham, and Andrew Tobias Pavia MD, Chief of the Division of Pediatric Infectious Diseases and Geographic Medicine at the University of Utah School of Medicine. Each witness will provide insight and testimony regarding the approval process of vaccines and the importance of maintaining transparency and accountability within government agencies.

The Biden administration’s decision to expedite vaccine approval led to concerns about potential harm among young Americans. The subcommittee will address these concerns during their hearing as well as discuss possible ways to ensure greater oversight in future approvals. This is an important issue that affects not only public health but also individual rights and freedoms. It is crucial that our government agencies maintain transparency and accountability in their decision-making processes to protect citizens from harm.